510(k) Report

510(k) · Cleared

Cleared

Captiam Syphilis-G Assay

K014233510(k) SpecialCleared Jan 24, 200229-day reviewClass II21 CFR 866.3830

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Trinity Biotech, Plc · LIP Enzyme Linked Immunoabsorption Assay, Treponema Pallidum

Cleared on Jan 24, 2002 after a 29-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 10 later devices descend from it.

Decided
Jan 24, 2002
Review
29 days
Class
Class II
Product code
LIP
Recalls
None
Predicates
0

10 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared2016: 3 descendants cleared2009: 1 descendant cleared2017: 1 descendant cleared2012: 1 descendant cleared2024: 2 descendants cleared2021: 1 descendant cleared200020052010201520202025
  1. This deviceK014233 Captiam Syphilis-G AssayTrinity Biotech, Plc · 2002
  2. Descendant · cites it directly · 9 of its ownK061247 Diasorin Liaison Treponema AssayDiaSorin, Inc. · 2006
  3. Descendant · 2 generations on · 5 of its ownK091361 Immulite 2000 Syphilis Screen Test SystemSiemens Healthcare Diagnostics · 2009 · Recalled
  4. Descendant · 3 generations on · 2 of its ownK160910 Elecsys SyphilisRoche Diagnostics · 2016
  5. Descendant · 4 generations on · 1 of its ownK211302 Elecsys SyphilisRoche Diagnostics · 2021
  6. Descendant · 2 generations on · 1 of its ownK153730 ARCHITECT Syphilis TP Reagent, ARCHITECT Syphilis TP Calibrator…Abbott Laboratories · 2016

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2006: 12009: 12012: 12016: 32017: 12021: 12024: 2
2006high 3 (2016) · low 0 (2007)2026

Most influential descendants

Showing 5 of 10 · See all
  • K061247Diasorin Liaison Treponema AssayDiaSorin, Inc. · 2006 · cites it directly9descendants
  • K091361Immulite 2000 Syphilis Screen Test SystemSiemens Healthcare Diagnostics · 2009 · 2 generations on5descendants
  • K160910Elecsys SyphilisRoche Diagnostics · 2016 · 3 generations on2descendants
  • K211302Elecsys SyphilisRoche Diagnostics · 2021 · 4 generations on1descendant
  • K153730ARCHITECT Syphilis TP Reagent, ARCHITECT Syphilis TP Calibrator, ARCHITECT Syphilis TP…Abbott Laboratories · 2016 · 2 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K014233Captiam Syphilis-G AssayTrinity Biotech, Plc2002—
+1K061247Diasorin Liaison Treponema AssayDiaSorin, Inc.2006—
+2K091361Immulite 2000 Syphilis Screen Test SystemSiemens Healthcare Diagnostics20092
+3K160910Elecsys SyphilisRoche Diagnostics2016—
+4K211302Elecsys SyphilisRoche Diagnostics2021—
+2K153730ARCHITECT Syphilis TP Reagent, ARCHITECT Syphilis TP Calibrator, ARCHITECT…Abbott Laboratories2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200910
201210
201630
201710
202110
202420
FIG. 1 — Lineage of K014233, 2002–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIP device

  1. #1 K241534 VITROS Immunodiagnostic Products Syphilis…score 9.1 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (10)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K061247Diasorin Liaison Treponema AssayDiaSorin, Inc.20069

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K061247 (DiaSorin, Inc., 2006) has gone furthest, with 9 descendants of its own.

How does its category compare?

All LIP devices

LIP Enzyme Linked Immunoabsorption Assay, Treponema Pallidum: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LIP

2in 2024

2007: 12009: 12010: 12011: 22012: 22016: 32017: 12021: 12024: 2
2007high 3 (2016) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIP

170in 2016

2016: 170 days median
2007high 170 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIP

2in 2022

2007: 22010: 12013: 12014: 12021: 22022: 22026 (partial year): 2
2007high 2 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LIP

112in 2025

2010: 12012: 12013: 42014: 12015: 22016: 12017: 32018: 52019: 92020: 462021: 542022: 442023: 662024: 732025: 112
2007high 112 (2025) · low 0 (2007)2025

MAUDE reports naming product code LIP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—20
20080—00
20091—00
20101—11
20112—00
20122—01
20130—14
20140—11
20150—02
2016317001
20171—03
20180—05
20190—09
20200—046
20211—254
20220—244
20230—066
20242—073
20250—0112
20260—2—

What is it indicated for?

CAPTIA™ Syphilis (T. pallidum )-G is an enzyme immunoassay for the qualitative detection of IgG antibodies to 7. pallidum in serum specimens, to be used in conjunction with non-treponemal testing to provide serological evidence of infection with 7. pallidum ( the agent of syphilis)

CAPTIA™ Syphilis (T. pallidum )-G is also intended for testing of serum or plasma specimens to screen blood and/or plasma donors to exclude a history of syphilis.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K014233: Captiam Syphilis-G Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K014233

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026